
    
      Dexmedetomidine, an alpha-2 adrenergic agonist, is being effectively used for procedural
      sedation or sedation at intensive care unit. However, the safety and efficacy profile are not
      yet established for children. Although there have been some studies regrading it, still there
      is no public guideline, therefore making it difficult to use dexmedetomidine in children.
    
  